Early response monitoring of neoadjuvant chemotherapy using [(18)F]FDG PET can predict the clinical outcome of extremity osteosarcoma

BACKGROUND: To propose a personalized therapeutic approach in osteosarcoma treatment, we assessed whether sequential [(18)F]FDG PET/CT (PET/CT) could predict the outcome of patients with osteosarcoma of the extremities after one cycle and two cycles of neoadjuvant chemotherapy. METHODS: A total of 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Inki, Byun, Byung Hyun, Lim, Ilhan, Kim, Byung Il, Choi, Chang Woon, Koh, Jae-Soo, Song, Won Seok, Cho, Wan Hyeong, Kong, Chang-Bae, Lim, Sang Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942108/
https://www.ncbi.nlm.nih.gov/pubmed/31900594
http://dx.doi.org/10.1186/s13550-019-0588-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942108/
https://www.ncbi.nlm.nih.gov/pubmed/31900594
http://dx.doi.org/10.1186/s13550-019-0588-4

Ejemplares similares